Circulating tumor cells as prognostic biomarkers in breast cancer: current status and future prospects

Expert Rev Mol Diagn. 2021 Oct;21(10):1037-1048. doi: 10.1080/14737159.2021.1962710. Epub 2021 Aug 9.

Abstract

Introduction : Despite advances in diagnostic and therapeutic techniques breast cancer is still associated with significant morbidity and mortality. CTCs play a crucial role in the metastatic process, which is the main cause of death in BC patients.Areas covered : This review discusses the prognostic and predictive value of CTCs and their prospective in management of BC patients.Expert opinion : The analysis of CTCs through improved technologies offers a new insight into the metastatic cascade. Assessment of the number and molecular profile of CTCs holds great promises for disease monitoring and therapeutic decisions. However, more research is needed until they can be used in therapeutic decisions in clinical practice.

Keywords: Breast cancer; biomarkers; circulating tumor cells; metastatic cascade; prognosis.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor
  • Breast Neoplasms* / pathology
  • Female
  • Humans
  • Neoplastic Cells, Circulating* / pathology
  • Prognosis
  • Prospective Studies

Substances

  • Biomarkers, Tumor